| Prev Close | 0.27 |
| Day Low/High | 0.24 / 0.27 |
| 52 Wk Low/High | 0.05 / 1.45 |
| Exchange | OTC Markets |
| Shares Outstanding | 79.80B |
| Market Cap | 21.39M |
| Div & Yield | N.A. (N.A) |
Premium Market Upgrade Better for Investors
Safe Home Phone service available in all 50 states
First Blockchain Company to Sign with Government Entity
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Synergetics USA, Inc.
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Synergetics USA, Inc.
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Synergetics USA,...
Kendall Law Group, led by former federal judge Joe Kendall, is investigating Synergetics USA, Inc.
Synergetics USA (SURG) shares are spiking after the company was acquired by Valeant Pharmaceuticals (VRX) for $166 million today.
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Synergetics USA, Inc.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Synergetics (SURG) stock is on the decline after reporting lower profit for its third quarter.
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Synergetics USA, Inc.
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Synergetics USA (Nasdaq:SURG) has been downgraded by TheStreet Ratings from from a buy to hold.
Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported growth in sales, gross...
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced that it plans to strengthen ...
Synergetics USA, Inc. (NASDAQ: SURG) announced that David M.
This isn't a core holding, per se, but it is a nicely tradable vehicle at this juncture.
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative devices for ophthalmic and neurosurgical applications, today announced two new ophthalmic products ...
Synergetics USA Inc was a winner within the health care sector, rising 5 cents (0.8%) to $6.11 on heavy volume.
Synergetic shares are plummeting in premarket trading after the company reported profit that was in line with expectations.
Synergetics USA, Inc. (NASDAQ: SURG), a medical device company that designs, manufactures, and markets innovative surgical devices for ophthalmic and neurosurgical applications, today reported record sales and net...
Major moves in volume can signal unusual activity in stocks; here are six stocks rising on unusual volume today.
